CI Cigna Group

NYSE cigna.com


$ 256.00 $ 14.21 (5.81 %)    

Monday, 03-Nov-2025 18:38:25 EST
QQQ $ 631.30 $ 3.01 (0.48 %)
DIA $ 472.86 $ -2.20 (-0.46 %)
SPY $ 682.63 $ 1.28 (0.19 %)
TLT $ 89.66 $ -0.55 (-0.61 %)
GLD $ 367.20 $ 0.66 (0.18 %)
$ 258.62
$ 242.00
$ 255.00 x 101
$ 258.00 x 638
$ 239.51 - $ 261.06
$ 239.51 - $ 346.57
5,412,531
na
69.08B
$ 0.50
$ 11.24
TBD
na
na ($ 0.02)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-30-2025 09-30-2025 10-Q
2 07-31-2025 06-30-2025 10-Q
3 05-02-2025 03-31-2025 10-Q
4 02-27-2025 01-01-1970 10-K
5 10-31-2024 09-30-2024 10-Q
6 08-01-2024 06-30-2024 10-Q
7 05-02-2024 03-31-2024 10-Q
8 02-29-2024 12-31-2023 10-K
9 11-02-2023 09-30-2023 10-Q
10 08-03-2023 06-30-2023 10-Q
11 05-05-2023 03-31-2023 10-Q
12 02-23-2023 12-31-2022 10-K
13 11-03-2022 09-30-2022 10-Q
14 08-04-2022 06-30-2022 10-Q
15 05-06-2022 03-31-2022 10-Q
16 02-24-2022 12-31-2021 10-K
17 11-04-2021 09-30-2021 10-Q
18 08-05-2021 06-30-2021 10-Q
19 05-07-2021 03-31-2021 10-Q
20 02-25-2021 12-31-2020 10-K
21 11-05-2020 09-30-2020 10-Q
22 08-06-2020 06-30-2020 10-Q
23 05-07-2020 03-31-2020 10-Q
24 02-27-2020 12-31-2019 10-K
25 10-31-2019 09-30-2019 10-Q
26 08-01-2019 06-30-2019 10-Q
27 05-02-2019 03-31-2019 10-Q
28 02-28-2019 12-31-2018 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 barclays-maintains-overweight-on-cigna-group-lowers-price-target-to-300

Barclays analyst Andrew Mok maintains Cigna Group (NYSE:CI) with a Overweight and lowers the price target from $383 to $300.

 fiserv-ebay-and-garmin-are-among-top-10-large-cap-losers-last-week-oct-27-oct-31-are-the-others-in-your-portfolio

These ten large-cap stocks led last week's declines, including Fiserv, Alexandria Real Estate, Chipotle, eBay, after weak r...

 cigna-forecasts-two-year-margin-strain-in-pharmacy-benefit-unit-stock-tanks

Cigna stock fell after Q3 results showed solid revenue but forecasted margin pressure in its pharmacy benefit services over the...

 meta-tumbles-10-google-marks-historic-rally-whats-moving-markets-thursday

Wall Street saw a cautious tone on Thursday as major tech-heavy indexes edged lower, weighed down by mixed earnings from the me...

 cigna-q3-total-pharmacy-customers-12249m-2-yoy-total-customer-relationships-1825m

Customer Relationships (in thousands): As of the Periods Ended September 30,June 30,December 31, 2025202420252024     Total Pha...

 cigna-group-reaffirms-fy2025-adj-eps-outlook-of-more-than-2960-vs-2963-est

2025 OUTLOOK2The Cigna Group's outlook2 for full year 2025 consolidated adjusted income from operations1,2 is at least $29....

 cigna-group-q3-adj-eps-783-beats-765-estimate-sales-69740b-beat-67110b-estimate

Cigna Group (NYSE:CI) reported quarterly earnings of $7.83 per share which beat the analyst consensus estimate of $7.65 by 2.38...

 unitedhealths-43-billion-profit-fueled-by-generosity-of-uncle-sam-says-healthcare-activist-government-drives-78-of-health-plan-revenue

Managed care company UnitedHealth Group Inc. reported $113 billion in revenue, up 12% year-over-year, and a profit of $4.3 bill...

 cignas-evernorth-launches-new-rebate-free-pharmacy-plan-to-lower-drug-costs-for-americans-unveils-transparent-prescription-model-promising-up-to-30-savings-on-brand-name-drugs

Evernorth, the health services division of The Cigna Group (NYSE:CI) today announced a new rebate-free pharmacy benefit model d...

 inflation-vs-reality-bilello-slams-clearly-wrong-government-data-claiming-health-insurance-prices-fell-18costs-only-go-in-one-direction

Charlie Bilello slams "absurd" gov't data claiming health insurance fell 18%. He says costs "only go in one dir...

 goldman-sachs-initiates-coverage-on-cigna-group-with-buy-rating-announces-price-target-of-370

Goldman Sachs analyst Scott Fidel initiates coverage on Cigna Group (NYSE:CI) with a Buy rating and announces Price Target ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION